Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 33 - Antiparasitic agents
Patents for A61P 33 - Antiparasitic agents (21,787)
12/2005
12/22/2005US20050281836 Synthetic vaccine for tick control
12/22/2005US20050281793 T cell activation
12/22/2005CA2567877A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
12/21/2005EP1607399A2 BIS-(N,N'-BIS-(2-Haloethyl)Amino) Phosphoramidates as antitumor agents
12/21/2005EP1278759B1 Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005EP1222200B1 Fusion protein between HPV-L1 and a peptide, capable of forming a VLP and that functions as a vehicle for introduction of a peptide in a cell and medical uses thereof
12/21/2005CN1711077A Combination product for controlling insect pests
12/21/2005CN1232539C Match of organic medicine and beta-cyclodextrin derivative and its preparing process
12/21/2005CN1232254C United slow release agent for preventing and treating piglet and rabbit coccidiosis and dysentery disease and its preparing method
12/21/2005CN1232253C Combined slow-release agent for preventing and treating domestic animal schistosome, fascioliasis, cestodiasis and nematodiasis disease and preparing method thereof
12/21/2005CN1232248C Combined sustained release agent and preparation thereof for preventing and treating livestock helminth, acarid and ectosarc disease
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977243 Crystal forms of azithromycin
12/20/2005US6977075 Administering to a patient having a disorder associtaed with an intracellular pathogen, a molecular conjugate of a photosensitizer and a targeting moiety, wherein the targeting moiety targets conjugate to the pathogen or infected cell
12/20/2005US6977070 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
12/15/2005US20050277609 Immunostimulatory nucleic acid molecules
12/15/2005US20050277604 Immunostimulatory nucleic acid molecules
12/15/2005CA2567803A1 Injectable pharmaceutical suspension comprising posaconazole
12/14/2005EP1604992A1 Process for the preparation of 10alpha-[4'-(S-S-Dioxothothiomorpholin-1'-yl)]-10-Deoxo-10-Dihydroartemisinin
12/14/2005EP1604650A2 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid
12/14/2005EP1326845B1 N-alkoxyalkyl-substituted benzimidazoles and the use thereof as an agent against parasitic protozoans
12/14/2005EP1242104B1 Process of obtaining thylakoids from plants, pure thylakoids and use thereof
12/14/2005CN1706847A Process for preparing 10alpha-[4'-(s,s-dioxothiomorpholin-1'-yl)]-10-deoxo-10-dihydroartemisinin
12/14/2005CN1231466C New piperidine derivatives
12/13/2005CA2324403C Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
12/08/2005WO2005116216A1 Oral vaccine against protozoiasis using genetically modified plant
12/08/2005US20050272935 A benzotriazolyl aminoacetonitrile compound ; pesticide; veterinary medicine
12/08/2005US20050272774 Substituted cyclohexane derivatives
12/08/2005US20050272708 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding
12/08/2005US20050272642 Protecting a muscarinic acetylcholine receptor in Alzheimer patients from oxidative stress, detoxification from toxic metal, by administering at least one pyrophosphates; prevent tissue damage, increasing the efficacy of a therapeutic agent
12/08/2005US20050271652 Treatment of pathologies which escape the immune response, using optimised antibodies
12/08/2005CA2567952A1 Oral anti-protozoiasis vaccines based on transgenic plants
12/07/2005EP1602368A2 Cdc25 phosphatase inhibitors
12/07/2005EP1601378A2 A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists
12/06/2005US6972343 such as N,N'-diformyl-N,N'-di[1-methyl-2-S-thiobenzoyl-4-methoxybut-1-enyl]-1,12-diaminododecane; for treatment of malaria
12/06/2005CA2349338C Novel macrolide antibiotics
12/01/2005US20050267201 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
12/01/2005US20050267200 Heteroaromate OSC inhibitors
12/01/2005US20050267165 Il-8 receptor antagonists
12/01/2005US20050267129 Dipeptide nitrile cathepsin K inhibitors
12/01/2005US20050267064 Containing unmethylated CpG dinucleotides, and an allergen; desensitization
12/01/2005US20050267057 Redirect a Th2 response to a Th1 response; treating asthma, allergies, infections, cancer immunotherapy; contain unmethylated cytosine-guanine (CpG) dinucleotides
12/01/2005US20050267048 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae
12/01/2005US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders
12/01/2005US20050266532 Albumin fusion proteins
12/01/2005US20050266485 polynucleotides encoding a hematopoietic cytokine receptor polypeptide, for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs; test detecting a genetic disorder, cancer
12/01/2005US20050266017 Plasmodium falciparum antigens inducing protective antibodies
11/2005
11/30/2005EP1599225A2 Compositions and methods for the generation of protective immune response against malaria
11/30/2005EP1599172A2 Methods for treatment of hiv or malaria using combinations of chloroquine and protease inhibitors
11/30/2005EP0871631B1 Antiparasitic marcfortines and paraherquamides
11/30/2005CN1703236A Use of il-2 receptor antibodies to prevent toxicity associated with amphotericin b antimycotic therapy
11/30/2005CN1229351C Heterocyclic compounds and methods to treat cardiac failure and other disorders
11/30/2005CN1229116C Injection of invermection for treating ox-warble myiosis
11/29/2005US6969728 Antiinflammatory agents
11/29/2005US6969508 Buccal aerosol sprays or capsules using polar and non-polar solvent which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect
11/29/2005CA2080545C Salts of hydrazones
11/24/2005WO2005110487A2 Camptothecin derivatives conjugated in position 20 with integrin antagonists
11/24/2005WO2005110486A2 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists
11/24/2005US20050260228 Vaccines absorbable by the transmucosal way
11/24/2005US20050260224 Vaccine based on a cellular penetration factor from an apicomplexan parasite
11/24/2005CA2562572A1 Camptothecin derivatives conjugated in position 20 with integrin antagonists
11/24/2005CA2562569A1 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists
11/23/2005EP1597264A2 Antiparasitic terpene alkaloids
11/23/2005EP1597249A1 Anthelmintic agents and insecticidal compositions
11/23/2005EP1296686B1 Praziquantel compositions for treating diseases caused by a coccidia
11/23/2005EP1039930B1 ADJUVANTED VACCINE COMPRISING AN ANTIGEN FROM STREPTOCOCCUS PNEUMONIAE AND A CpG OLIGONUCLEOTIDE
11/23/2005EP0988309B1 C-4''-substituted macrolide derivatives
11/23/2005CN1701116A Probiotic bacterium: lactobacillus fermentum
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1227977C Composition of N-phenyl-N'-benzoyl carbamide derivant and stem protein compound for preventing vermin
11/22/2005US6967205 Compounds with antibacterial and antiparasitic properties
11/22/2005US6967090 Nucleic acid and protein sequences of bovine epidermal growth factor
11/17/2005WO2005065063A3 Use of the mushroom agaricus blazei murill for the production of medicaments suitable for treating infections and allergies
11/17/2005US20050256148 Topoisomerase I inhibitors; improved stability, water solubility, toxicity; anticancer agents; camptothecins bearing an oxime group in position 7; 7-tert-butoxyiminomethyl-20-O-(4-trimethyl-ammonium-3-hydroxy)butanoyl-camptothecin bromide; parasitic or viral infections
11/17/2005US20050256122 Substituted pyridazinones
11/17/2005US20050256066 Fredericamycin derivatives
11/17/2005US20050256063 Crystal forms of azithromycin
11/17/2005US20050256062 A tablet of a crystalline form of azithromycin sesquihydrate or crystalline azithromycin monohydrate hemi-isopropanol solvate and a carrier or diluent; nuclear magnetic resonance spectrum analysis; bactericides; antiprotozoa agents; infections of humans, mammals, birds, fish; drug resistance
11/17/2005US20050255156 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
11/16/2005EP1594866A1 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives
11/16/2005EP1594828A1 Antimicrobial trinervitane derivatives
11/16/2005EP1379138B1 Liquid formulations for dermal application in treatment of parasitic insects in animals
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1107767B1 Use of selenium for treating systemic inflammatory response syndrome (sirs), and composition for implementing said treatment
11/16/2005EP0871703B1 Dna encoding glutamate gated chloride channels
11/16/2005CN1697655A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/16/2005CN1227258C Use of azalide antibiotic compositions for treating or preventing bacterial or protozoal infection in mammals
11/16/2005CN1227248C Imidazolidine derivatives, their preparation, and their use as antinflamatory agent
11/16/2005CN1227228C Delta 1-pyrrolines used as pesticides
11/16/2005CN1227030C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
11/15/2005US6964974 2,3-oxidosqualene-lanosterol cyclase inhibitors
11/15/2005US6964946 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
11/15/2005US6964762 Composition and method for stimulating immune response to pathogen using complex adenoviral vector
11/10/2005US20050250716 Immunostimulatory oligodeoxynucleotides
11/10/2005US20050249838 Use of fermented wheat-germ in the feeding and veterinary practice
11/10/2005US20050249750 Universal T-cell epitopes for anti-malarial vaccines
11/10/2005US20050249701 Il-7 Drug substance, composition, preparation and uses
11/09/2005EP1592700A2 Avermectin- and avermectin monosaccharide derivatives substituted in the 4''- or 4'- position having pesticidal properties
11/09/2005EP1592699A1 AVERMECTIN AND AVERMECTIN MONOSACCHARIDE DERIVATIVES SUBSTITUTED IN THE 4”- OR 4’-POSITION HAVING PESTICIDAL PROPERTIES
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 218